SCHEDULE 13G/A: BlackRock Updates Significant Stake in CVS Health, Maintains 7.1% Ownership
Beneficial Ownership Statement Amendment
BlackRock, Inc. has filed an Amendment No. 13 to its Schedule 13G, disclosing a 7.1% beneficial ownership stake in CVS Health Corporation as of March 31, 2025.
Summary
- BlackRock, Inc. reported beneficial ownership of 89,218,268 shares of CVS Health Corporation common stock.
- This ownership represents 7.1% of CVS Health's total outstanding common stock.
- BlackRock holds sole voting power over 80,083,037 shares and sole dispositive power over 89,218,268 shares.
- The filing is an Amendment No. 13 to a previously filed Schedule 13G, indicating an update to their ownership disclosure.
- BlackRock certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of CVS Health.
- BlackRock Fund Managers Ltd., a subsidiary of BlackRock, Inc., is identified as an entity that beneficially owns 5% or greater of the outstanding shares of CVS Health.
Sentiment
Score: 6
Explanation: Slightly positive. While a routine regulatory filing, the maintenance of a significant stake by a major institutional investor like BlackRock can be interpreted as a vote of confidence in CVS Health's long-term prospects.
Positives
- BlackRock, a leading global asset manager, maintains a substantial 7.1% stake in CVS Health, signaling continued institutional confidence in the company's long-term prospects.
- The filing explicitly states that the holding is for investment purposes in the ordinary course of business, suggesting a stable, non-activist investment approach.
Risks
- The filing explicitly states that the securities were not acquired or held for the purpose of changing or influencing the control of the issuer, mitigating concerns about potential activist investor intervention.
Future Outlook
NA
Industry Context
This filing reflects the routine investment activities of BlackRock, one of the world's largest asset managers, in major U.S. corporations like CVS Health. Significant institutional holdings are typical for large-cap companies in stable sectors such as healthcare, indicating a baseline level of institutional confidence in the sector and the specific company.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Attorney-in-fact | Multiple individuals from a Power of Attorney dated April 30, 2023 | Eric Andruczyk, Richard Cundiff, R. Andrew Dickson, III, Spencer Fleming, Laura Hildner, David Maryles, Christopher Meade, Charles Park, James Raby, Daniel Riemer, David Rothenberg, Brenda Schulz | 2025-01-21 | Issuance of a new Power of Attorney, expressly revoking the previous one, to authorize specific individuals to execute and file ownership or control-person reporting requirements on behalf of BlackRock, Inc. and its subsidiaries. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney Update | BlackRock, Inc. issued a new Power of Attorney, effective January 21, 2025, authorizing a list of individuals to execute and file various SEC and other regulatory documents related to ownership and control-person reporting. This new Power of Attorney expressly revokes the one dated April 30, 2023. | 2025-01-21 | Streamlines BlackRock's internal compliance processes for regulatory filings by designating specific individuals with the authority to act on its behalf. |
Stakeholder Impact
- Shareholders: The continued significant ownership by a major institutional investor like BlackRock may instill confidence among existing and potential shareholders, suggesting a stable long-term investment.
Key Dates
| Date | Description |
|---|---|
| 2023-04-30 | Date of the previously issued Power of Attorney that was expressly revoked. |
| 2025-01-21 | Effective date of the new Power of Attorney issued by BlackRock, Inc. |
| 2025-03-31 | Date of the event which required the filing of this Schedule 13G Amendment. |
| 2025-04-17 | Date of filing of this Schedule 13G Amendment No. 13. |
Keywords
BlackRock, CVS Health Corporation, Schedule 13G, Beneficial Ownership, Institutional Investor, Healthcare, Pharmacy, Asset Management, SEC Filing, Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.